For healthcare professionals only

Letters Trachoma control

Authors’ reply to Solomon writing on behalf of 18 others

BMJ 2012; 344 doi: (Published 10 April 2012) Cite this as: BMJ 2012;344:e2588
  1. R Baltussen, senior researcher1,
  2. A Smith, honorary professor2,
  3. D Chisholm, health economist3
  1. 1Department of Primary and Community Care, Radboud University, Nijmegen Medical Centre, Netherlands
  2. 2International Centre for Evidence on Disability, London School of Hygiene and Tropical Medicine, London, UK
  3. 3Department of Health Systems Financing, WHO, Geneva, Switzerland
  1. r.baltussen{at}

Solomon and colleagues inappropriately label our analysis of trachoma control erroneous, but their comments are largely related to methodological issues in (standardised WHO-CHOICE) cost effectiveness analysis and present gaps in knowledge.1 2

Firstly, mass treatment with antibiotics of all residents is probably more effective and costly than treatment of children. Whether the first intervention is cost effective according to international thresholds, and more cost effective …

View Full Text

Log in

Log in through your institution


* For online subscription